News Detail
NEW DELHI/MUMBAI, 23 FEB 2025: The government on Sunday said the combination of tapentadol and carisoprodol drugs is not approved in India, and prohibited production and export of such medicines, amid reports that an Indian company has been exporting the unlicensed combination.
Source : Economic Times
industry news
industry growth
indian industry news
aveo pharma
tapentadol
carisoprodol
opiod
cdsco
Related News
- Stop Production Order issued to Aveo Pharmaceuticals on 22nd February: Govt (24-02-2025)
- USFDA pulls up Jagsonpal Pharma for manufacturing lapses Bhiwadi API plant (24-02-2025)
- 2500 narcotic pills recovered in Sirsa, supplier arrested (23-02-2025)
- Maha FDA Issues Show Cause Notice to Aveo for Illegal Export of Opioids (23-02-2025)
- Trump pushes drugmakers to shift overseas production to US or face tariffs: Report (23-02-2025)
- Blood banks found illegally trafficking blood obtained from social organization camps, selling each unit for Rs 1500 in Uttar Pradesh and Chhattisgarh (23-02-2025)
- Hyderabad: Unlicensed Ayurvedic Practitioner Arrested for Selling Unauthorized Medicines (23-02-2025)
- Attempt to get medicines by using doctor's fake seal and signature, FIR lodged (23-02-2025)
- Two youths arrested with 1780 narcotic capsules in Sri Ganganagar (23-02-2025)
- Counterfeit Medicines Valued Over Rs 1 Crore already in circulation (22-02-2025)